Cigna Group (CI) Net Equity Issued and Repurchased (2018 - 2026)

Cigna has reported Net Equity Issued and Repurchased for 9 years, with the latest figure at $101.0 million in Q2 2026.

• Quarterly Net Equity Issued and Repurchased rose 40.28% year-over-year to $101.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $220.0 million (down 2.22% YoY) and the FY2025 annual result came in at $203.0 million, down 33.44% from the prior year.
• Net Equity Issued and Repurchased improved to $101.0 million in Q2 2026 per CI's latest filing, from $57.0 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $181.0 million in Q1 2024 and troughed at $22.0 million in Q4 2024.
• A 5-year average of $69.0 million and a median of $65.5 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased jumped 809.09% in 2022, then slumped 76.61% in 2023.
• Over 5 years, Net Equity Issued and Repurchased stood at $72.0 million in 2022, then increased by 2.78% to $74.0 million in 2023, then slumped by 70.27% to $22.0 million in 2024, then advanced by 13.64% to $25.0 million in 2025, then soared by 304.0% to $101.0 million in 2026.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $101.0 million, $57.0 million, and $25.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.